Rhythm Pharmaceuticals, Inc. (RYTM)
NASDAQ: RYTM · Real-Time Price · USD
99.77
-2.35 (-2.30%)
At close: Sep 8, 2025, 4:00 PM
99.31
-0.46 (-0.46%)
Pre-market: Sep 9, 2025, 5:18 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
Therapeutics
130.13M
Log In
Log In
Log In
Therapeutics Growth
68.06%
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21
United States
96.11M
Log In
Log In
Log In
United States Growth
53.96%
Log In
Log In
Log In
International
34.02M
Log In
Log In
Log In
Germany
-
Log In
Log In
Log In
Other
-
Log In
Log In
Log In